Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
Hydroxylamine was evaluated and found to be a highly effective agent for the in vitro prevention of penicillin inactivation of tobramycin. This inactivation reaction resulted in an underestimation of tobramycin concentrations and was dependent on time, temperature, amount and type of penicillin, and amount of tobramycin. Plasma samples containing tobramycin and three clinically relevant concentrations of ticarcillin, carbenicillin, azlocillin, or piperacillin were incubated with and without hydroxylamine, and tobramycin concentrations were monitored at 0, 12, 24, 48, and 72 h. The inactivation reaction was found to be completely inhibited by hydroxylamine (1 mg/ml) compared with a 27 to 50% loss of measured tobramycin concentration in the unprotected tobramycin-penicillin samples. Hydroxylamine did not interfere with the Emit enzyme immunoassay (Syva Co.) at either high or low tobramycin concentrations. Hydroxylamine was effective in inhibiting the tobramycin inactivation at both room and refrigerator temperatures and was 100% effective in protecting tobramycin on a 1:1 molar basis.
D001390:Azlocillin / Q000494:pharmacology; D002228:Carbenicillin / Q000494:pharmacology; D002435:Cefamandole / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D019811:Hydroxylamine; D006898:Hydroxylamines / Q000494:pharmacology*; D007124:Immunoenzyme Techniques; D066298:In Vitro Techniques; D009070:Moxalactam / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology*; D010878:Piperacillin / Q000494:pharmacology; D013982:Ticarcillin / Q000494:pharmacology; D014031:Tobramycin / Q000037:antagonists & inhibitors* / Q000097:blood
D006898:Hydroxylamines; D010406:Penicillins; D019811:Hydroxylamine; D002435:Cefamandole; D013982:Ticarcillin; D002228:Carbenicillin; D001390:Azlocillin; D009070:Moxalactam; D014031:Tobramycin; D010878:Piperacillin